XML 44 R43.htm IDEA: XBRL DOCUMENT v2.4.0.8
SUMMARY OF SIGNIFICANT ACCOUNT POLICIES Change in Accounting Principle (Details) (USD $)
In Thousands, except Per Share data, unless otherwise specified
 3 Months Ended 12 Months Ended
Dec. 31, 2013
Sep. 30, 2013
Jun. 30, 2013
Mar. 31, 2013
Dec. 31, 2012
Sep. 30, 2012
Jun. 30, 2012
Mar. 31, 2012
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
New Accounting Pronouncements or Change in Accounting Principle [Line Items]                      
Inventories, net $ 206,919       $ 171,806       $ 206,919 $ 171,806  
Cost of goods sold                 327,045 314,427 299,150
Selling, general and administrative                 407,802 373,114 358,132
Provision (benefit) for income taxes                 (10,235) 10,825 505
Net income (loss) 13,771 [1] (30,330) [1] 1,520 [1] (6,028) [1] 12,786 13,211 8,514 6,693 (21,067) 41,204 27,989
Earnings Per Share, Basic                 $ (0.74) $ 1.46 $ 0.97
Earnings Per Share, Diluted                 $ (0.74) $ 1.44 $ 0.95
Comprehensive Income (Loss), Net of Tax, Attributable to Parent                 (15,343) 45,500 20,691
Deferred tax assets 48,616       39,100       48,616 39,100  
Prepaid expenses and other current assets 26,858       30,291       26,858 30,291  
Retained earnings 280,956       302,023       280,956 302,023  
Deferred Income Tax Expense (Benefit)                 (13,145) 1,537 1,156
Increase (Decrease) in Inventories                 (35,505) (711) 1,702
Increase (Decrease) in Prepaid Expense and Other Assets                 4,823 (3,067) (395)
Previously reported [Member]
                      
New Accounting Pronouncements or Change in Accounting Principle [Line Items]                      
Inventories, net 213,431               213,431    
Cost of goods sold                 334,085    
Selling, general and administrative                 394,250    
Provision (benefit) for income taxes                 (7,813)    
Net income (loss)                 (16,977)    
Earnings Per Share, Basic                 $ (0.60)    
Earnings Per Share, Diluted                 $ (0.60)    
Comprehensive Income (Loss), Net of Tax, Attributable to Parent                 (11,253)    
Deferred tax assets 46,300               46,300    
Prepaid expenses and other current assets 26,752               26,752    
Retained earnings 285,046               285,046    
Deferred Income Tax Expense (Benefit)                 (10,829)    
Increase (Decrease) in Inventories                 (42,017)    
Increase (Decrease) in Prepaid Expense and Other Assets                 4,929    
Restatement Adjustment [Member]
                      
New Accounting Pronouncements or Change in Accounting Principle [Line Items]                      
Inventories, net (6,512)               (6,512)    
Cost of goods sold                 (7,040)    
Selling, general and administrative                 13,552    
Provision (benefit) for income taxes 1,000               (2,422)    
Net income (loss)                 (4,090)    
Comprehensive Income (Loss), Net of Tax, Attributable to Parent                 (4,090)    
Deferred tax assets 2,316               2,316    
Prepaid expenses and other current assets 106               106    
Retained earnings (4,090)               (4,090)    
Deferred Income Tax Expense (Benefit)                 (2,316)    
Increase (Decrease) in Inventories                 6,512    
Increase (Decrease) in Prepaid Expense and Other Assets                 $ (106)    
[1] The first quarter of 2013 was negatively impacted by a voluntary recall of certain products manufactured in the Company's Añasco, Puerto Rico facility.On July 31, 2013, the Company performed the annual goodwill impairment test which resulted in a non-cash goodwill impairment charge of $46.7 million for its U.S. Spine reporting unit, which is a part of the U.S. Spine and Other reportable segment. The Company incurred incremental costs related to the implementation of its global enterprise resource planning system in the first, second, third, and fourth quarters of 2013 of $6.1 million, $7.6 million, $5.0 million and $5.6 million, respectively.The Company incurred costs related to the remediation of the FDA warning letters at its manufacturing facilities of $2.1 million, $3.0 million, $2.8 million and $0.4 million in the first, second, third and fourth quarters of 2013, respectively.